NAFPENZAL DC, intramaminė suspensija
NAFPENZAL DC, intramaminė suspensija
Authorised
- Nafcillin
- Dihydrostreptomycin sulfate
- Benzylpenicillin procaine
Product identification
Medicine name:
NAFPENZAL DC, intramaminė suspensija
Active substance:
- Nafcillin
- Dihydrostreptomycin sulfate
- Benzylpenicillin procaine
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Nafcillin100.00milligram(s)1.00Syringe
-
Dihydrostreptomycin sulfate100.00milligram(s)1.00Syringe
-
Benzylpenicillin procaine300.00milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (dry cow)
-
Meat and offal14day
-
Milk36hourJei užtrūkimo periodas trumpesnis nei 6 sav., pieną reikia ištirti dėl antibiotikų liekanų
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RC23
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/93/0047/001-002
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 11/01/2023
How useful was this page?: